Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma

Published:2023-01 Issue: Volume:Volume 10 Page:113-122
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Yang Xue,Chang Jing,Li Ruili,Qi Yu,Zeng Xufen,Wang Wei,Li Hongjun

Publisher

Informa UK Limited

Subject

General Medicine

Reference29 articles.

1. Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma

2. Combined hepatocellular-cholangiocarcinoma: An update

3. cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation

4. Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma

5. LI-RADS categories: concepts, definitions, and criteria

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined hepatocellular-cholangiocarcinoma and hepatocellular carcinoma: Differentiation using radiomics based on Multitemporal CT images;2024-02-12

2. Current advances and future directions in combined hepatocellular and cholangiocarcinoma;Gastroenterology Report;2023-12-22

3. The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value;La radiologia medica;2023-07-20

4. Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data;European Journal of Radiology;2023-06